Latest news with #CORONARemedies
Economic Times
17-07-2025
- Business
- Economic Times
CORONA Remedies acquires 7 brands from Bayer's pharma division in India
CORONA Remedies on Thursday said it has acquired seven brands from the pharmaceutical division of Bayer in India for an undisclosed sum. The acquisition includes brands in the cardiology segment (Noklot) and women's healthcare portfolio (Fostine, Luprofact, Menodac, Ovidac, Spye and Vageston) in the Indian market, the company said in a statement. Through the acquisition, the company said it is entering the anti-platelet monotherapy segment while also increasing presence in the cardiology domain.
Time of India
17-07-2025
- Business
- Time of India
CORONA Remedies acquires 7 brands from Bayer's pharma division in India
CORONA Remedies on Thursday said it has acquired seven brands from the pharmaceutical division of Bayer in India for an undisclosed sum. The acquisition includes brands in the cardiology segment (Noklot) and women's healthcare portfolio (Fostine, Luprofact, Menodac, Ovidac, Spye and Vageston) in the Indian market , the company said in a statement. Explore courses from Top Institutes in Select a Course Category Public Policy Artificial Intelligence Product Management Digital Marketing Cybersecurity Technology MBA CXO Healthcare Others Data Science Leadership PGDM Design Thinking healthcare Operations Management Data Analytics Data Science Project Management others Management MCA Finance Degree Skills you'll gain: Economics for Public Policy Making Quantitative Techniques Public & Project Finance Law, Health & Urban Development Policy Duration: 12 Months IIM Kozhikode Professional Certificate Programme in Public Policy Management Starts on Mar 3, 2024 Get Details Skills you'll gain: Duration: 12 Months IIM Calcutta Executive Programme in Public Policy and Management Starts on undefined Get Details Through the acquisition, the company said it is entering the anti-platelet monotherapy segment while also increasing presence in the cardiology domain.
